STAT

JULY 29, 2024

Sarepta Therapeutics demanded a prominent patient advocacy organization censor a video that contained pointed criticism of the company’s recently approved gene therapy for Duchenne muscular dystrophy, STAT has learned. The incident raises questions about the financial ties between Sarepta and the advocacy group, Parent Project Muscular Dystrophy, and whether the drugmaker uses its money to influence, or even muzzle, debate over its Duchenne medicines.

361

361

PharmaVoice

AUGUST 2, 2024

As AI tools move from hype to a daily reality at pharma companies, here are the insights users are gaining.

278

278

Pharma Times

JULY 29, 2024

Coronary heart disease is the most common form of heart and circulatory disease

142

142

BioPharma Dive

JULY 30, 2024

The company is letting go of 150 staffers alongside a decision to officially terminate the high-profile program, which was acquired in 2016.

136

136

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

STAT

AUGUST 1, 2024

Malaria is one of our most ancient foes — and one of the wiliest. Caused by parasites that certain mosquitoes spread through their bites, malaria overwhelms us, establishing an infection before we can put up a fight. It can go on to destroy red blood cells, batter organs, and even damage the brain.

Vaccines 358

Vaccines 358

PharmaVoice

AUGUST 1, 2024

From an epic, alternative reality fantasy to a ‘biography of cancer,’ these six reads have stuck with pharma execs as they navigate how to lead.

265

265

The Pharmacist

JULY 31, 2024

More and more pharmacies are closing as a six-month delay to the community pharmacy contract means core funding has still not been uplifted since 2019. Contractors told The Pharmacist that they struggle to keep up with increased demand for services and the knock-on impact of pressure elsewhere in the health system, while being unable to pay their […] The post Pharmacy contract delays causing 'stress, uncertainty and closures' appeared first on The Pharmacist.

Community Pharmacies 131

Community Pharmacies 131

STAT

AUGUST 2, 2024

Where and when the Covid-19 pandemic began — in Wuhan, China in late 2019 — is well known. How it began is a matter of heated controversy. There are two competing hypotheses, one of which is hindering the process of scientific discovery and could hold back the development of vaccines and other antiviral agents in the U.S. The zoonosis hypothesis proposes that SARS-CoV-2, the virus that causes Covid-19, was naturally transmitted from an animal to one or more humans in a so-called we

Vaccines 357

Vaccines 357

PharmaVoice

JULY 31, 2024

The U.S. government will demand payment from Big Pharma to make up for dozens of drugs with prices that rose faster than the rate of inflation.

246

246

Pharma Times

AUGUST 2, 2024

Cancer is estimated to affect more than three million people living in the UK, according to Macmillan Cancer Support

126

126

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

BioPharma Dive

AUGUST 2, 2024

Adaptimmune’s Tecelra is the first TCR cell therapy to reach market and, at $727,000, is also the priciest cellular medicine for cancer in the U.S.

124

124

STAT

JULY 31, 2024

Mount Sinai, a leading hospital network in New York City, has mounted an extraordinary behind-the-scenes campaign to blunt the fallout over revelations about its controversial research project in which brain biopsies are taken from patients undergoing deep brain stimulation, STAT has learned. That has included not only enlisting its own patients to defend the research but also seeking to stop a professional society of neurosurgeons from issuing a statement that could have jeopardized the researc

Documentation 345

Documentation Hospitals 345

PharmaVoice

JULY 29, 2024

A brain-on-a-chip developer says better preclinical modeling could help move the needle.

162

162

Pharma Times

AUGUST 2, 2024

The third leading cause of cancer mortality accounts for over 700,000 deaths every year

119

119

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

BioPharma Dive

AUGUST 1, 2024

The drug led to a 38% reduction in the risk of death or complications from a type of heart failure, a finding that compared favorably to available treatments.

124

124

STAT

JULY 29, 2024

The Food and Drug Administration on Monday approved a blood test intended to detect colon cancer, a product many experts hope will help catch cases of the disease early enough so that they can be more easily treated. The test, called Shield and made by Guardant Health, a Palo Alto, Calif.-based biotech firm, comes with a drawback: It is not as good as a colonoscopy and other tests at detecting precancerous or early stage cancers.

343

343

PharmaVoice

AUGUST 1, 2024

The CEO noted how Pfizer's danuglipron could still be the second oral GLP-1 treatment to enter registrational tests after Lilly's orforglipron.

130

130

pharmaphorum

JULY 31, 2024

Vertex has filed for FDA approval of its non-opioid pain drug suzetrigine, starting the clock ticking on a review that should be completed early next year

119

119

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

BioPharma Dive

AUGUST 1, 2024

The biotech cited competitive pressure and “very low” expected sales in Europe for its latest guidance cut, which sent shares down by nearly 20%.

121

121

STAT

JULY 29, 2024

With the number of U.S. dairy herds infected with H5N1 bird flu rising almost daily, fears are growing that the dangerous virus cannot be driven out of this species. That belief is amplifying calls for the development of flu shots for cows. Multiple animal vaccine manufacturers are reportedly at work trying to develop such products. And the U.S. Department of Agriculture is eagerly encouraging the effort, detailing in a notice last week what kinds of evidence would be needed to win licensing app

Vaccines 337

Vaccines 337

PharmaVoice

JULY 30, 2024

Dupixent hasn’t generated as much buzz as top-sellers like Keytruda or Ozempic, but the drug is boosting Sanofi’s earnings into the future.

130

130

pharmaphorum

JULY 31, 2024

Frontiers Health 2024 is a platform connecting innovators and changemakers in the life sciences industry to cultivate positive changes in health systems. Discover the latest trends and insights in healthcare innovation.

119

119

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

BioPharma Dive

JULY 31, 2024

Launched last September, the company is working on a treatment for alpha-1 antitrypsin deficiency, which it said could enter the clinic in 2025.

119

119

STAT

JULY 30, 2024

As the AI race in dentistry grows more heated, a startup called Perceptive is aiming to automate each stage of a dental visit, from imaging to treatment recommendations to the actual surgical procedure. The Boston startup, which recently came out of stealth mode, announced on Tuesday that it has received $30 million in funding to work on a dental system that includes a hand-held imaging machine, an AI algorithm to help diagnose and suggest treatment, and a surgical robot to complete the procedur

335

335

PharmaVoice

JULY 29, 2024

The mid-stage failure leaves the success of the expensive partnership hanging on a drug that’s already suffered its own setback.

130

130

Pharma Times

JULY 31, 2024

Quantum-based technologies will explore infectious diseases, cancer and dementia

119

119

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

pharmaphorum

AUGUST 2, 2024

Eli Lilly's dual GLP-1/GIP agonist tirzepatide has been shown to reduce the risk of worsening disease in people with heart failure and obesity in a phase 3 trial, the first to show a benefit on cardiovascular outcomes with the drug.

117

117

STAT

JULY 30, 2024

The Centers for Disease Control and Prevention announced Tuesday that it is funding a $5 million program to vaccinate livestock industry workers against seasonal flu in a bid to reduce the pandemic risk posed by the ongoing H5N1 bird flu outbreak in cattle. The voluntary program, which will be administered by state and local public health workers, is aimed at getting seasonal flu shots into as many people as possible who are working in proximity to animals — poultry, cows, or other livest

Vaccines 330

Vaccines 330

The Pharmacist

JULY 30, 2024

The number of students passing the summer pharmacist registration exam is the lowest it has been in four years, figures published today have revealed. Just 75% of trainee pharmacists passed the common registration assessment for pharmacists this year, held jointly by the General Pharmaceutical Council (GPhC) and Pharmaceutical Society of Northern Ireland (PSNI).

117

117

BioPharma Dive

AUGUST 1, 2024

The job cuts affects 65% of UniQure’s workforce and include the gene therapy developer’s recent sale of a manufacturing plant to Genezen.

116

116

pharmaphorum

JULY 30, 2024

Discover how OPEN Health and fusion's AI technology partnership is creating a symbiotic relationship that is revolutionising healthcare. Explore the benefits of this for optimal patient care.

117

117